Suppression of Tie-1 in endothelial cells in vitro induces a change in the genome-wide expression profile reflecting an inflammatory function

von Chan, Barden, Sukhatme, Vikas P.
Veröffentlicht 2009

Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro

von Chan, Barden, Sukhatme, Vikas P.
Veröffentlicht 2008

Available drugs and supplements for rapid deployment for treatment of COVID-19

von Cicka, Danielle, Sukhatme, Vikas P
Veröffentlicht in J Mol Cell Biol (2021)

Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology

von Husain, Zaheed, Seth, Pankaj, Sukhatme, Vikas P
Veröffentlicht 2013

Bovine and Rodent Tamm-Horsfall Protein (THP) Genes: Cloning, Structural Analysis, and Promoter Identification

von Yu, Heron, Papa, Feroz, Sukhatme, Vikas P
Veröffentlicht in Gene Expr (2018)

High Cell Density Induces Vascular Endothelial Growth Factor Expression Via Protein Tyrosine Phosphorylation

von Mukhopadhyay, Debabrata, Tsiokas, Leonidas, Sukhatme, Vikas P.
Veröffentlicht in Gene Expr (2018)

Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2

von Tsiokas, Leonidas, Kim, Emily, Arnould, Thierry, Sukhatme, Vikas P., Walz, Gerd
Veröffentlicht 1997

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent

von Pantziarka, Pan, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vidula, Sukhatme, Vikas P
Veröffentlicht 2014

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent

von Pantziarka, Pan, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vidula, Sukhatme, Vikas P
Veröffentlicht in Ecancermedicalscience (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent

von Pantziarka, Pan, Sukhatme, Vidula, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vikas P
Veröffentlicht in Ecancermedicalscience (2015)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent

von Sukhatme, Vidula, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vikas P, Pantziarka, Pan
Veröffentlicht in Ecancermedicalscience (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

von Pantziarka, Pan, Sukhatme, Vidula, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vikas P
Veröffentlicht in Ecancermedicalscience (2016)

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

von Sukhatme, Vikas P., Reiersen, Angela M., Vayttaden, Sharat J., Sukhatme, Vidula V.
Veröffentlicht in Front Pharmacol (2021)

Specific association of the gene product of PKD2 with the TRPC1 channel

von Tsiokas, Leonidas, Arnould, Thierry, Zhu, Chenwen, Kim, Emily, Walz, Gerd, Sukhatme, Vikas P.
Veröffentlicht 1999

Induction of Erythroid Differentiation in Human Erythroleukemia Cells by Depletion of Malic Enzyme 2

von Ren, Jian-Guo, Seth, Pankaj, Everett, Peter, Clish, Clary B., Sukhatme, Vikas P.
Veröffentlicht 2010

Cellular Actions and Signaling by Endostatin

von Ramchandran, Ramani, Karumanchi, S. Ananth, Hanai, Jun-ichi, Alper, Seth L., Sukhatme, Vikas P.
Veröffentlicht 2002

The Repurposing Drugs in Oncology (ReDO) Project

von Pantziarka, Pan, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vidula, Sukhatme, Vikas P., Vikas, P.
Veröffentlicht 2014

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent

von Pantziarka, Pan, Bouche, Gauthier, Sukhatme, Vidula, Meheus, Lydie, Rooman, Ilse, Sukhatme, Vikas P
Veröffentlicht in Ecancermedicalscience (2016)

Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents

von Pantziarka, Pan, Sukhatme, Vidula, Crispino, Sergio, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vikas P
Veröffentlicht in Ecancermedicalscience (2018)

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent

von Van Nuffel, An MT, Sukhatme, Vidula, Pantziarka, Pan, Meheus, Lydie, Sukhatme, Vikas P, Bouche, Gauthier
Veröffentlicht in Ecancermedicalscience (2015)